Literature DB >> 18675886

Extended fear conditioning reveals a role for both N-methyl-D-aspartic acid and non-N-methyl-D-aspartic acid receptors in the amygdala in the acquisition of conditioned fear.

P J Pistell1, W A Falls.   

Abstract

Pavlovian conditioning is a useful tool for elucidating the neural mechanisms involved with learning and memory, especially in regard to the stimuli associated with aversive events. The amygdala has been repeatedly implicated as playing a significant role in the acquisition and expression of fear. If the amygdala is critical for the acquisition of fear, then it should contribute to this processes regardless of the parameters used to induce or evaluate conditioned fear. A series of experiments using reversible inactivation techniques evaluated the role of the amygdala in the acquisition of conditioned fear when training was conducted over several days in rats. Fear-potentiated startle was used to evaluate the acquisition of conditioned fear. Pretraining infusions of N-methyl-d-aspartic acid (NMDA) or non-NMDA receptor antagonists alone into the amygdala interfered with the acquisition of fear early in training, but not later. Pretraining infusions of a cocktail consisting of both an NMDA and non-NMDA antagonist interfered with the acquisition of conditioned fear across all days of training. Taken together these results suggest the amygdala may potentially be critical for the acquisition of conditioned fear regardless of the parameters utilized.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675886      PMCID: PMC2749992          DOI: 10.1016/j.neuroscience.2008.07.012

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  72 in total

1.  Neurotoxic basolateral amygdala lesions impair learning and memory but not the performance of conditional fear in rats.

Authors:  S Maren
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations.

Authors:  K Nader; J E LeDoux
Journal:  Behav Neurosci       Date:  1999-10       Impact factor: 1.912

3.  L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala.

Authors:  M G Weisskopf; E P Bauer; J E LeDoux
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

Review 4.  Emotion circuits in the brain.

Authors:  J E LeDoux
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

Review 5.  Long-term potentiation in the amygdala: a mechanism for emotional learning and memory.

Authors:  S Maren
Journal:  Trends Neurosci       Date:  1999-12       Impact factor: 13.837

6.  A role for amygdaloid PKA and PKC in the acquisition of long-term conditional fear memories in rats.

Authors:  K A Goosens; W Holt; S Maren
Journal:  Behav Brain Res       Date:  2000-09       Impact factor: 3.332

7.  Posttraining lesions of the amygdala interfere with fear-potentiated startle to both visual and auditory conditioned stimuli in C57BL/6J mice.

Authors:  S Heldt; V Sundin; J F Willott; W A Falls
Journal:  Behav Neurosci       Date:  2000-08       Impact factor: 1.912

8.  Scopolamine and Pavlovian fear conditioning in rats: dose-effect analysis.

Authors:  S G Anagnostaras; S Maren; J R Sage; S Goodrich; M S Fanselow
Journal:  Neuropsychopharmacology       Date:  1999-12       Impact factor: 7.853

9.  Fear-potentiated startle in rats is mediated by neurons in the deep layers of the superior colliculus/deep mesencephalic nucleus of the rostral midbrain through the glutamate non-NMDA receptors.

Authors:  Zuowei Zhao; Michael Davis
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

10.  Conditioned suppression and freezing as measures of aversive Pavlovian conditioning: effects of discrete amygdala lesions and overtraining.

Authors:  Jonathan L C Lee; Anthony Dickinson; Barry J Everitt
Journal:  Behav Brain Res       Date:  2004-12-09       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.